Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO)
CUSIP: 09075F305
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 138,961,039
- Total 13F shares
- 1
- Share change
- +1
- Total reported value
- $3
- Price per share
- $3.00
- Number of holders
- 1
- Value change
- +$3
- Number of buys
- 1
Quarterly Holders Quick Answers
What is CUSIP 09075F305?
CUSIP 09075F305 identifies BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09075F305:
Top shareholders of BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Soheil Shams |
3/4/5
|
Chief Informatics Officer |
—
mixed-class rows
|
5,556,479
mixed-class rows
|
$3,217,163 | — | 15 Feb 2022 | |
| CVI Investments, Inc. |
13D/G
|
— |
7.7%
|
10,700,000
|
$1,284,000 | $0 | 03 Jan 2025 | |
| Christopher P. Stewart |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
281,373
|
$180,810 | — | 12 May 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.45%
|
49,979
|
$139,442 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
15,506
|
$43,266 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.11%
|
11,991
|
$33,455 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.09%
|
10,103
|
$28,187 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
8,393
|
$23,417 | — | 31 Mar 2025 | |
| Gulsen Kama |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
91,000
mixed-class rows
|
$20,320 | — | 03 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.03%
|
3,208
|
$8,946 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
2,373
|
$6,621 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.02%
|
1,790
|
$4,994 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
262
|
$731 | — | 31 Mar 2025 | |
| COLDSTREAM CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
138
|
$386 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
114
|
$318 | — | 31 Mar 2025 | |
| Rise Advisors, LLC |
13F
|
Company |
0%
|
106
|
$296 | — | 31 Mar 2025 | |
| CREDIT AGRICOLE S A |
13F
|
Individual |
0%
|
44
|
$123 | — | 31 Mar 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
41
|
$114 | — | 31 Mar 2025 | |
| GPS Wealth Strategies Group, LLC |
13F
|
Company |
0%
|
16
|
$45 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
13
|
$36 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
11
|
$31 | — | 31 Mar 2025 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
6
|
$26 | — | 31 Mar 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
5
|
$16 | — | 31 Mar 2025 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
4
|
$12 | — | 31 Mar 2025 | |
| Activest Wealth Management |
13F
|
Company |
0%
|
3
|
$8 | — | 31 Mar 2025 | |
| AllSquare Wealth Management LLC |
13F
|
Company |
0%
|
3
|
$8 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
3
|
$8 | — | 31 Mar 2025 | |
| Pandora Wealth, Inc. |
13F
|
Company |
0%
|
3
|
$8 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
2
|
$6 | — | 31 Mar 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
2
|
$6 | — | 31 Mar 2025 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
1
|
$3 | — | 31 Mar 2025 | |
| Aviso Financial Inc. |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Mar 2025 | |
| Richard Shippy |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
550,000
|
— | — | 15 Feb 2022 | |
| Robert J. Priar |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
400,000
|
— | — | 01 Jun 2021 | |
| Vincent Jung-Fai Wong |
3/4/5
|
Director |
—
class O/S missing
|
30,000
|
— | — | 18 Jun 2024 | |
| Albert Luderer |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| Aleksandar Rajkovic |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| Christopher J. Twomey |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| David L. Barker |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| Hannah Mamuszka |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| Kristiina Vuori MD |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 | |
| Yvonne Linney |
3/4/5
|
Director |
—
class O/S missing
|
2,775
|
— | — | 11 Jun 2025 |
Institutional Holders of Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) as of Q2 2025
As of 30 Jun 2025,
Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
1 shares.
The largest 1 holders included
Ancora Advisors LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
0
Q2 2025 holders
1
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.